July 14, 2025Recent data shows a significant decline in historically problematic drug classes in workers’ compensation, particularly opioids, followed by muscle relaxants, benzodiazepines, sedatives, and central nervous system stimulants. While continued vigilance related to the use of these drug classes is necessary, attention must also shift to emerging trends to provide the best possible claims outcomes. “Dermatologicals […]